发明名称 COMPOSITION FOR TREATING DIABETES, COMPRISING LONG-ACTING INSULIN ANALOGUE CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE
摘要 The present invention relates to a composition for preventing or treating diabetes mellitus comprising insulin and a GLP-1/glucagon dual agonist, and a method for preventing or treating diabetes mellitus. More specifically, the present composition can inhibit the weight gain and reduce the danger of hypoglycemia due to the administration of insulin, lower the administration dose and greatly improve the compliance of drugs through a combined administration of a long-acting insulin conjugate and a long-acting GLP-1/glucagon dual agonist conjugate. In addition, the long-acting insulin conjugate and the long-acting GLP-1/glucagon dual agonist conjugate according to the present invention can improve the in vivo sustainability and stability because an insulin and a GLP-1/glucagon dual agonist are linked to the immunoglobulin Fc region via a non-peptidyl linker.
申请公布号 PH12016502391(A1) 申请公布日期 2017.02.20
申请号 PH12016502391 申请日期 2016.11.29
申请人 HANMI PHARM. CO., LTD. 发明人 KIM, JUNG KUK;KIM, DAE JIN;HEO, YONG HO;CHOI, IN YOUNG;JUNG, SUNG YOUB;KWON, SE CHANG
分类号 A61K38/26;A61K38/28;A61K47/30 主分类号 A61K38/26
代理机构 代理人
主权项
地址